As of December 4, 2025, the primary market buzzes with excitement around three standout IPOs: Meesho, Aequs, and Vidya Wires. Grey Market Premiums (GMPs) serve as the unofficial crystal ball for potential listing gains, and today’s figures paint a vibrant picture. Meesho IPO GMP holds steady at around 41%, signaling robust investor confidence in this e-commerce giant.
Meanwhile, Aequs IPO’s final decision leans toward strong subscription potential with a GMP of 37%, making it a compelling choice for aerospace enthusiasts. Vidya Wires IPO GMP, though modest at 11%, underscores steady demand in the manufacturing sector.
This comprehensive guide dives deep into all IPO GMP today, offering expert insights, subscription updates, and strategic advice. Whether you’re a seasoned trader eyeing listing pops or a long-term investor scouting undervalued gems, we break down why these IPOs dominate headlines.
Drawing from real-time market data, financial analyses, and industry trends, we equip you to make informed decisions. Remember, while GMPs hint at hype, always align investments with your risk appetite—markets reward the prepared.
Understanding Grey Market Premium (GMP) in Today’s IPO Landscape
Grey Market Premiums represent the unofficial trading of IPO shares before their official listing, giving savvy investors a sneak peek into market sentiment. In simple terms, GMP is the price difference between the IPO issue price and what unlisted shares fetch in the grey market. A higher GMP, like Meesho’s 41% today, suggests buyers anticipate significant listing gains, often fueled by strong fundamentals and hype.
Why does GMP matter in all IPO GMP today? It acts as a barometer for subscription rates and post-listing performance. For instance, a 10% GMP typically translates to modest 5-8% listing pops after accounting for volatility, while 40%+ premiums, as seen with Meesho, can yield 20-30% returns on debut. However, GMPs fluctuate wildly—rising on positive news like anchor investments or dipping on economic jitters.
In December 2025, India’s IPO market thrives amid economic recovery, with over ₹15,000 crore raised year-to-date. Factors like falling interest rates and booming sectors (e-commerce, aerospace, manufacturing) amplify GMP trends. Investors track platforms like Chittorgarh and IPO Watch for live updates, but pros caution: GMP isn’t a guarantee. Pair it with subscription status, peer valuations, and company financials for a holistic view.
Historically, high-GMP IPOs like Zomato (2021) delivered 65% listing gains, but laggards like Paytm crashed post-debut. Today’s trio—Meesho IPO GMP, Aequs IPO GMP, and Vidya Wires IPO GMP—mirrors this mix of opportunity and caution. As we explore each, note how GMP correlates with retail frenzy: Meesho’s retail quota oversubscribed 5x already, per BSE data.
Meesho IPO GMP Today: 41% Premium Signals E-Commerce Boom
Meesho, the SoftBank-backed e-commerce powerhouse, storms the market with its ₹5,421 crore IPO, open from December 3 to 5, 2025. Priced at ₹105-111 per share, it values the company at a whopping ₹50,096 crore—making it one of 2025’s largest offerings. Today’s Meesho IPO GMP clocks in at ₹46, implying a listing price of ₹157 (41.44% above the cap). This surge from yesterday’s ₹42 reflects Day 2 subscription hitting 3.48x overall, with retail at 5x.
Founded in 2015 as FashNear Technologies, Meesho revolutionized social commerce by empowering Tier-2/3 city resellers. Its zero-commission, asset-light model integrates sellers, buyers, logistics (via Valmo), and creators, boasting 213 million annual transacting users. In FY25, revenue soared 28% to ₹7,200 crore, though net losses widened to ₹3,942 crore due to expansion costs. Analysts at Motilal Oswal praise its “defensible logistics flywheel” and Bharat penetration, projecting profitability by FY27.
Proceeds fund cloud infrastructure (₹1,200 crore), marketing (₹800 crore), acquisitions, and corporate needs. Anchor investors like BlackRock poured ₹2,439 crore, signaling institutional faith. Meesho IPO subscription status shines: QIBs at 2x, NIIs at 4x. Lot size: 135 shares (minimum ₹14,985). Allotment finalizes December 8, listing December 10 on BSE/NSE.
Should you apply? Absolutely, for listing gains—GMP trends upward amid festive sales tailwinds. Long-term holders eye 2-3x returns as India’s e-commerce hits $350 billion by 2030. Risks? Intense competition from Flipkart/Amazon and regulatory e-commerce scrutiny. Yet, with 40%+ GMP, Meesho leads all IPO GMP today for short-term thrill-seekers.
(Word count so far: ~650; expanding sections below for depth.)
Aequs IPO Final Decision: GMP at 37% Backs Aerospace Ambitions
Precision engineering meets sky-high potential in Aequs IPO, a ₹922 crore issue (fresh ₹670 crore + OFS ₹252 crore) priced at ₹118-124 per share. As Day 2 unfolds on December 4, 2025, Aequs IPO GMP stands at ₹46, forecasting a ₹170 listing (37.5% premium). This follows a stellar Day 1 subscription of 3.42x, with retail at 11.46x—eclipsing expectations for this Belagavi-based SEZ specialist.
Established in 2000, Aequs crafts aerospace components (88% revenue) for giants like Boeing and Airbus, plus diversifying into consumer electronics. Its vertically integrated Belagavi SEZ—spanning machining, assembly, and testing—employs 1,892 staff and serves global OEMs. FY25 saw revenue dip 3% to ₹1,131 crore, with PAT plunging 619% to a ₹142 crore loss, hit by debt (₹533 crore) and capex depreciation. Yet, H1 FY26 rebounded with ₹566 crore revenue and narrowing losses.
IPO funds repay debt (₹453 crore) and fuel consumer segment growth, targeting laptops/smart devices. Anchors like SBI Funds chipped in ₹414 crore. Aequs IPO final decision? Experts at Anand Rathi rate it “Subscribe” for long-term plays, citing 8.9x FY25 P/S valuation and EV/EBITDA at 123x—premium but justified by aerospace tailwinds (global market: $1 trillion by 2040).
Lot size: 120 shares (₹14,880 minimum). Allotment: December 8; listing: December 10. GMP’s steady climb from ₹44.5 signals QIB inflows, but volatility looms from cyclical aviation demand. For risk-tolerant investors, Aequs promises 30%+ pops; conservative ones, await post-listing dips for entry.
Vidya Wires IPO GMP Today: Steady 11% Amid Manufacturing Resilience
Rounding out the trio, Vidya Wires IPO raises ₹300 crore (fresh ₹274 crore + OFS ₹26 crore) at ₹48-52 per share, with Vidya Wires IPO GMP at ₹6 (11.54% premium, listing at ₹58). Day 2 subscription hits 5x, retail 6x, per NSE— a solid debut for this 1993-vintage conductor maker.
Vidya Wires dominates winding wires and enamelled copper/aluminium products for motors, transformers, and EVs. With 35% retail quota, it caters to industrials via ISO-certified plants in Jaipur. FY25 revenue grew 15% to ₹450 crore, PAT up 20% to ₹35 crore, boasting 18% margins. Expansion targets EV/auto segments, leveraging India’s $500 billion electronics push.
Anchors contributed ₹90 crore. Proceeds build new facilities via subsidiary ALCU and debt repayment. Lot: 288 shares (₹14,976). Allotment: December 8; listing: December 10. GMP’s modest rise from ₹5 reflects steady, not flashy, demand—ideal for value hunters.
Vidya Wires IPO review: “Long-term buy” per IDBI Capital, with 12x P/E vs. peers’ 15x. Risks include raw material volatility (copper prices up 10% YTD). In all IPO GMP today, it lags flashier peers but shines for diversification.
Comparative Analysis: Meesho vs Aequs vs Vidya Wires IPO GMP and Subscription
| Parameter | Meesho | Aequs | Vidya Wires |
|---|---|---|---|
| Issue Size | ₹5,421 Cr | ₹922 Cr | ₹300 Cr |
| Price Band | ₹105-111 | ₹118-124 | ₹48-52 |
| GMP Today | ₹46 (41%) | ₹46 (37%) | ₹6 (11%) |
| Subscription (Day 2) | 3.48x (Retail 5x) | 5x (Retail 11x) | 5x (Retail 6x) |
| Sector | E-commerce | Aerospace/Precision Engg | Conductors/Manufacturing |
| Valuation (P/S FY25) | 7x | 8.9x | 1.5x |
| Expected Listing Gain | 35-40% | 30-35% | 8-12% |
| Risk Level | High (Loss-making) | Medium (Cyclical) | Low (Profitable) |
Meesho leads in scale and hype, Aequs in growth potential, Vidya in stability. GMPs correlate with subscriptions: High retail bids boost premiums. For portfolios, allocate 40% Meesho (growth), 30% Aequs (niche), 30% Vidya (defensive).
Investment Strategies: How to Maximize Returns from These IPOs
Navigating IPO GMP today demands strategy. For listing gains, apply via multiple family accounts to beat oversubscription—UPI mandates cut-off at 5 PM December 5. Use ASBA for safety.
Long-term? Meesho suits digital bulls; hold 2-3 years for 3x upside. Aequs appeals to Make-in-India believers, targeting 50% CAGR in aerospace exports. Vidya Wires offers dividend stability (yield 2%).
Diversify: Cap exposure at 5-10% portfolio. Monitor RBI cues—rate cuts could lift all boats. Tools like Zerodha’s IPO analyzer help track allotments.
Tax tip: STT on listing gains taxes as business income (30%); hold >1 year for LTCG (10% over ₹1 lakh).
Risks and Regulatory Nuances in Current IPO GMP Trends
No rainbow without rain—all IPO GMP today hides pitfalls. Meesho’s losses (₹3,942 Cr FY25) flag burn rates; Aequs’s debt (0.98x equity) risks defaults; Vidya’s copper dependency ties to commodities.
Regulatory: SEBI’s T+3 settlement speeds refunds but amps volatility. Global factors—US Fed hikes—could dampen FII flows.
Mitigate: Read RHPs, consult SEBI-registered advisors. GMPs, while exciting, ignore fundamentals; 20% of 2025 IPOs listed flat.
Future Outlook: What’s Next for IPO GMP in December 2025?
December sizzles with Wakefit (GMP 18%) and Corona Remedies (29%) up next. Overall, 2025’s ₹2 lakh crore pipeline signals bull run, per JM Financial. E-commerce and manufacturing lead, but watch SMEs for multibaggers.
In conclusion, Meesho IPO GMP, Aequs IPO GMP, and Vidya Wires IPO GMP spotlight diverse opportunities. Act swiftly—subscribe by tomorrow, track allotments via KFin/MUFG Intime. Invest wisely; fortunes favor the bold yet briefed.